NCT00679055 - A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 26, 2008

Study Completion Date

August 26, 2008

Conditions

Peripheral Vascular Diseases

Interventions

DRUG

MK-0736

MK-0736; 7mg once daily, orally at approximately the same time each morning for 12 weeks.

DRUG

Comparator: placebo (unspecified)

Matching Placebo once daily, orally at approximately the same time each morning for 12 weeks.